Natasha B Khazai1, George R Beck, Guillermo E Umpierrez. 1. Division of Endocrinology, Diabetes & Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA. nkhazai@emory.edu
Abstract
PURPOSE OF REVIEW: To review recent literature on fracture risk in patients with type 1 and type 2 diabetes. RECENT FINDINGS: Observational and population studies have reported a higher risk of fractures in patients with type 1 and type 2 diabetes, especially at the hip. Type 2 diabetic patients have a higher bone mineral density compared with the general population, and yet, remain unprotected from fractures. Type 1 diabetic patients have a greater risk of fractures and a lower bone mineral density compared with the general population. Their lower bone mineral density, however, does not fully account for the raised fracture risk. Therefore, impaired bone quality rather than lower bone density appears to mediate the increased fracture risk in patients with type 1 and 2 diabetes.Recently, studies have shown an association between advanced glycation end products with increased fracture risk in diabetic patients. These studies support the hypothesis of poor glycemic control and chronic hyperglycemia having a direct detrimental effect on bone quality. In addition, increased fracture risk has been reported in patients with peripheral and autonomic neuropathy, recurrent hypoglycemic events, vitamin D deficiency, and those receiving thiazolidinedione therapy. SUMMARY: Diabetes is associated with an increased risk of fractures in patients with type 1 and type 2 diabetes. Appropriate measures aimed at fracture prevention should be considered in the complex care of the diabetic patient.
PURPOSE OF REVIEW: To review recent literature on fracture risk in patients with type 1 and type 2 diabetes. RECENT FINDINGS: Observational and population studies have reported a higher risk of fractures in patients with type 1 and type 2 diabetes, especially at the hip. Type 2 diabeticpatients have a higher bone mineral density compared with the general population, and yet, remain unprotected from fractures. Type 1 diabeticpatients have a greater risk of fractures and a lower bone mineral density compared with the general population. Their lower bone mineral density, however, does not fully account for the raised fracture risk. Therefore, impaired bone quality rather than lower bone density appears to mediate the increased fracture risk in patients with type 1 and 2 diabetes.Recently, studies have shown an association between advanced glycation end products with increased fracture risk in diabeticpatients. These studies support the hypothesis of poor glycemic control and chronic hyperglycemia having a direct detrimental effect on bone quality. In addition, increased fracture risk has been reported in patients with peripheral and autonomic neuropathy, recurrent hypoglycemic events, vitamin D deficiency, and those receiving thiazolidinedione therapy. SUMMARY:Diabetes is associated with an increased risk of fractures in patients with type 1 and type 2 diabetes. Appropriate measures aimed at fracture prevention should be considered in the complex care of the diabeticpatient.
Authors: A V Schwartz; D E Sellmeyer; K E Ensrud; J A Cauley; H K Tabor; P J Schreiner; S A Jamal; D M Black; S R Cummings Journal: J Clin Endocrinol Metab Date: 2001-01 Impact factor: 5.958
Authors: Kenneth J Ottenbacher; Glenn V Ostir; M Kristen Peek; James S Goodwin; Kyriakos S Markides Journal: J Gerontol A Biol Sci Med Sci Date: 2002-10 Impact factor: 6.053
Authors: Ann V Schwartz; Eric Vittinghoff; Deborah E Sellmeyer; Kenneth R Feingold; Nathalie de Rekeneire; Elsa S Strotmeyer; Ronald I Shorr; Aaron I Vinik; Michelle C Odden; Seok Won Park; Kimberly A Faulkner; Tamara B Harris Journal: Diabetes Care Date: 2007-12-04 Impact factor: 19.112
Authors: Christoph Wallner; Stephanie Abraham; Johannes Maximilian Wagner; Kamran Harati; Britta Ismer; Lukas Kessler; Hannah Zöllner; Marcus Lehnhardt; Björn Behr Journal: Stem Cells Transl Med Date: 2016-04-21 Impact factor: 6.940
Authors: Kang I Ko; Leila S Coimbra; Chen Tian; Jazia Alblowi; Rayyan A Kayal; Thomas A Einhorn; Louis C Gerstenfeld; Robert J Pignolo; Dana T Graves Journal: Diabetologia Date: 2015-01-07 Impact factor: 10.122
Authors: Dana L Catalfamo; Nadia L Calderon; Scott W Harden; Heather L Sorenson; Kathleen G Neiva; Shannon M Wallet Journal: J Cell Physiol Date: 2013-02 Impact factor: 6.384
Authors: Preethi Srikanthan; Carolyn J Crandall; Dana Miller-Martinez; Teresa E Seeman; Gail A Greendale; Neil Binkley; Arun S Karlamangla Journal: J Bone Miner Res Date: 2014-04 Impact factor: 6.741